HomeOwner SearchCategory Search
Visit USCOSpecific blood coagulation inhibitors associated with lymphoproliferative disorders Susan Solymoss, Edwin G. Bovill
Text Registration
Copyright Title
Specific blood coagulation inhibitors associated with lymphoproliferative disorders Susan Solymoss, Edwin G. Bovill
Status
Published
on 13 Jun 2007
Year of Creation
1989
Copyright Claimant
American Society of Clinical Pathologists
Registration Number
PA0000484950
on 13 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: PA0000484950) dated 13 Jun 2007, pertains to an electronic file (eService) titled "Specific blood coagulation inhibitors associated with lymphoproliferative disorders Susan Solymoss, Edwin G. Bovill" created in 1989. The copyright holder is American Society of Clinical Pathologists, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to American Society of Clinical Pathologists.
Application Details
Registration Number
PA0000484950
Registration Date
6/13/2007
Year of Creation
1989
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
10 p. + slides
Series Statement
Thrombosis and hemostasis no. TH 86-6 (TH-48) Check Sample continuing education program
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.